Е. А. Гофман
National Research Center for Preventive Medicine · 17 works · 14 citations · h-index 3
Top works
- FIRST RESULTS OF CHD PROGNOSIS STUDY
- Novel Scale for Long-Term Prognostication of Risk of Death and Nonfatal Cardiovascular Complications in Patients From the PROGNOSIS-IHD Registry
- DEVELOPING A REGISTER OF OUTCOMES OF CHRONIC CORONARY HEART DISEASE: CHD PROGNOSIS STUDY
- PROGNOSTIC VALUE OF INTSTRUMENTAL DIAGNOSTICS IN CHRONIC CORONARY HEART DISEASE. DATA FROM “PROGNOS CHD”
- Эффективность и безопасность лекарственной терапии при первичной и вторичной профилактике сердечно-сосудистых заболеваний
- UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
- Маркетинговое исследование удовлетворенности пациентов качеством предоставляемых медицинских услуг в РГКП «Национальный центр гигиены труда и профессиональных заболеваний» МЗСР РК
- VALUE OF SPECIFIC PARAMETERS AND INTEGRATIVE INDICES OF TREADMILL TEST FOR THE ASSESSMENT OF CORONARY STENOSIS SEVERITY
- Изучение приверженности лечению статинами у пациентов с хронической ишемической болезнью сердца и соответствия гиполипидемической терапии клиническим рекомендациям (по данным регистра ПРОГНОЗ ИБС)
- EFFICACY AND SAFETY OF CARVEDILOL VERSUS METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY
- UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
- Современная терапия антиагрегантами больных с высоким риском тромбообразования и реальная клиническая практика
- Five year prognosis in patients with angiographically proven stable coronary heart disease: results of prospective observational study in russia.
- UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
- A STUDY OF LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE VERIFIED BY CORONARY ANGIOGRAPHY: RESULTS OF OBSERVATION FOR PATIENTS INCLUDED IN THE REGISTER OF NATIONAL RESEARCH CENTER FOR PREVENTIVE MEDICINE
- COMPARATIVE STUDY OF ORIGINAL AND GENERIC RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH RISK OF CARDIOVASCULAR COMPLICATIONS